Antioxidant could lead to safer thalidomide

2017-06-23 05:00:08

ONE OF the big questions about the drug thalidomide was why the birth defects that affected thousands of babies in the 1950s did not show up in tests on mice. Now the compound that protected mice has been identified, and could lead to safer versions of the drug, which has been rehabilitated as a powerful anti-cancer agent. Jürgen Knobloch, now at the University of Cologne in Germany,